Insider activities archive   |   Recent insider buys   |   Top 10 insider buys   |   Search Insiders!



Insider Trading: Protalix Biotherapeutics, Inc.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Protalix Biotherapeutics, Inc. since year 2005 are given in the first table. The second table lists detailed insider transactions reported by Protalix Biotherapeutics, Inc. since 2005. The reporting company's ticker symbol is PLX. The reporting company's CIK number is 1006281. The total value of stock buying during this period is $126,227. The total value of stock sales is $219,684. The total value of stock exercises is $103,014.

Figure 1. Monthly insider transaction values at Protalix Biotherapeutics, Inc. (PLX) in the past 24 months. The trade values of insider stock buys, sales, and option exercises are in logarithmic scale as shown on the right axis labels. The detailed monthly and daily insider transactions are listed in the 2 tables below.

  • 06

  • 07

  • 08

  • 09

  • 10

  • 11

  • 12

  • 01 2007

  • 02

  • 03

  • 04

  • 05

  • 06

  • 07

  • 08

  • 09

  • 10

  • 11

  • 12

  • 01 2008

  • 02

  • 03

  • 04

  • 05

  • $113,924

    $11,392

    $1,139

    $113

  • Buy
  • Sale
  • Option Exercise

Figure 2. Average prices of insider buys, sales, and option exercises at Protalix Biotherapeutics, Inc. (PLX) in the past 24 months. See table 2 for insider transaction details.

  • 06

  • 07

  • 08

  • 09

  • 10

  • 11

  • 12

  • 01 2007

  • 02

  • 03

  • 04

  • 05

  • 06

  • 07

  • 08

  • 09

  • 10

  • 11

  • 12

  • 01 2008

  • 02

  • 03

  • 04

  • 05

  • $3.31

    $2.48

    $1.66

    $.83



Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Protalix Biotherapeutics, Inc. (PLX).
Trading Period
year-month  
Insider Buying     
Shares               Value ($)
Insider Sales     
Shares               Value ($)
Option Exercises     
Shares               Value ($)
2008-05 0 0 41,427 113,924 48,370 19,251
2008-03 10,000 28,833 0 0 0 0
2008-02 0 0 33,300 105,760 86,176 83,763
2007-12 30,000 97,394 0 0 0 0

Table 2. Detailed insider stock purchases, sales, and option exercises for Protalix Biotherapeutics, Inc. (PLX)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2008-05-12 Almon Einat Brill (VP, Product Development) Sale 41,427 2.75 113,924
2008-05-11 Almon Einat Brill (VP, Product Development) Option Exercise 48,370 .40 19,251
2008-03-11 Frost Gamma Investment Trust (10% Owner) Purchase 10,000 2.88 28,833
2008-02-25 Yossi Maimon (VP, Chief Financial Officer) Sale 33,300 3.18 105,760
2008-02-22 Yossi Maimon (VP, Chief Financial Officer) Option Exercise 86,176 .97 83,763
2007-12-19 Shaaltiel Yoseph (Executive VP, R&D) Purchase 4,800 3.40 16,320
2007-12-18 Shaaltiel Yoseph (Executive VP, R&D) Purchase 5,100 3.38 17,212
2007-12-17 Shaaltiel Yoseph (Executive VP, R&D) Purchase 5,000 3.35 16,750
2007-12-05 Shaaltiel Yoseph (Executive VP, R&D) Purchase 15,100 3.12 47,112

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Protalix Biotherapeutics, Inc. (symbol PLX, CIK number 1006281) see the Securities and Exchange Commission (SEC) website.

© 2005-2008, insider-monitor.com. All rights reserved.